New chemo cocktail shows promise for tough head and neck cancers
NCT ID NCT04356170
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 23 times
Summary
This study tested a combination of three chemotherapy drugs (cisplatin, 5-fluorouracil, and docetaxel) at lower, adjusted doses in 105 people with advanced head and neck cancer that could not be surgically removed. The goal was to see if the treatment could shrink tumors effectively while reducing severe side effects. The main outcome measured was the success rate of treatment after 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER OF HEAD AND NECK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Leon Berard
Lyon, 69008, France
Conditions
Explore the condition pages connected to this study.